Anti-IFNGR1 抗体 [BB1E2] (FITC) (ab11286)


  • 製品名Anti-IFNGR1 antibody [BB1E2] (FITC)
    IFNGR1 一次抗体 製品一覧
  • 製品の詳細
    Mouse monoclonal [BB1E2] to IFNGR1 (FITC)
  • 標識FITC. Ex: 493nm, Em: 528nm
  • 特異性This antibody recognises human IFNGR1, expressed by monocytes, and very weakly by resting peripheral blood lymphocytes.
  • アプリケーション適用あり: Flow Cytmore details
  • 種交差性
    交差種: Human
  • 免疫原

    Fusion protein of the extracellular part of the human interferon-gamma receptor (AA: Ala17-Gly245) to 11 AA of the c-myc proto-oncogene (for affinity purification).

  • 特記事項This product should be stored undiluted. Storage in frost-free freezers is not recommended. This product is photosensitive and should be protected from light. Should this product contain a precipitate we recommend microcentrifugation before use.



Our Abpromise guarantee covers the use of ab11286 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
Flow Cyt
  • 追加情報Flow Cyt: Use neat. Use 10µl of the suggested working dilution to label 106 cells in 100µl.
    Not tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • ターゲット情報

    • 機能Receptor for interferon gamma. Two receptors bind one interferon gamma dimer.
    • 関連疾患Defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease (MSMD) [MIM:209950]; also known as familial disseminated atypical mycobacterial infection. This rare condition confers predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine and environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. The pathogenic mechanism underlying MSMD is the impairment of interferon-gamma mediated immunity whose severity determines the clinical outcome. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance.
    • 配列類似性Belongs to the type II cytokine receptor family.
      Contains 2 fibronectin type-III domains.
      Contains 2 Ig-like C2-type (immunoglobulin-like) domains.
    • 翻訳後修飾Phosphorylated at Ser/Thr residues.
    • 細胞内局在Membrane.
    • Information by UniProt
    • 参照データベース
    • 別名
      • Antiviral Protein Type II antibody
      • Antiviral protein, type 2 antibody
      • AVP type II antibody
      • AVP, type 2 antibody
      • CD 119 antibody
      • CD119 antibody
      • CD119 antigen antibody
      • CDw119 antibody
      • FLJ45734 antibody
      • IFN gamma R alpha antibody
      • IFN gamma R antibody
      • IFN gamma R1 antibody
      • IFN-gamma receptor 1 antibody
      • IFN-gamma-R1 antibody
      • IFNG R1 antibody
      • IFNGR 1 antibody
      • IFNGR antibody
      • IFNGR1 antibody
      • Immune interferon receptor 1 antibody
      • Immune interferon receptor for antibody
      • INGR1_HUMAN antibody
      • Interferon gamma receptor 1 antibody
      • Interferon gamma receptor alpha chain antibody
      • Interferon gamma receptor alpha chain precursor antibody
      see all

    Anti-IFNGR1 antibody [BB1E2] (FITC) 画像

    • ab11286 staining IFNGR1 in human peripheral blood monocytes by Flow Cytometry analysis.

    Anti-IFNGR1 antibody [BB1E2] (FITC) (ab11286) 使用論文

    ab11286 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab11286.
    Please use the links above to contact us or submit feedback about this product.